Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancer
The pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) of breast cancer is closely related to a better prognosis. However, there are no reliable indicators to accurately identify which pati...
Source: BMC Medicine - Category: Internal Medicine Authors: Zhaoyun Liu, Bo Yu, Mu Su, Chenxi Yuan, Cuicui Liu, Xinzhao Wang, Xiang Song, Chao Li, Fukai Wang, Jianli Ma, Meng Wu, Dawei Chen, Jinming Yu and Zhiyong Yu Tags: Research article Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Internal Medicine | Men | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy